SEC Form 4 · accession 0001127602-17-024126
GILEAD SCIENCES, INC. · GILD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gregg H Alton
Officer — EVP Comm&Acs ALA, Corp&Med Aff
Period of report
Jul 21, 2017
Accepted (ET)
Jul 25, 2017 · 6:53 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000882095
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 21, 2017 | M | 34,500 | $26.99 | A | 137,488 | D | |
| Common Stock | Jul 21, 2017 | S | 34,500 | $74.00 | D | 102,988 | D | |
| Common Stock | Jul 21, 2017 | S | 5,500 | $74.00 | D | 97,488 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-qualified Stock Option (Right to Buy)F2 | $26.99 | Jul 21, 2017 | M | 34,500 | D | — | Jul 30, 2018 | Common Stock | 34,500 | 29,626 | D |
Explanation of responses
- F1The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.
- F2Options vest over a five year period with 20% vesting July 30, 2009, the first anniversary of the grant. The options continue to vest in quarterly installments over the next four years, and will be fully vested on July 30, 2013.